Tumor-conditioned Gr-1+CD11b+ myeloid cells induce angiogenesis through the synergistic action of CCL2 and CXCL16 in vitro

Biochemical and Biophysical Research Communications

Volumn 443, Issue 4, 2014, Pages 1218-1225

  Han, Eun Chun ^a   Lee, Jungwhoi ^a   Ryu, Seung Wook ^a   Choi, Chulhee ^a  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

Angiogenesis; CCL2; CXCL16; Gr 1+CD11b+ myeloid cells

Indexed keywords

ANGIOGENESIS; CCL2; CXCL16; GR-1(+)CD11B(+) MYELOID CELLS;

ANIMALS; ANTIGENS, CD11B; CELL LINE, TUMOR; CHEMOKINE CCL2; CHEMOKINE CXCL6; CULTURE MEDIA, CONDITIONED; FEMALE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; IMMUNE TOLERANCE; MAMMARY NEOPLASMS, EXPERIMENTAL; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED BALB C; MYELOID CELLS; NEOVASCULARIZATION, PATHOLOGIC; NEUTRALIZATION TESTS; RECEPTORS, CHEMOKINE; TUMOR MICROENVIRONMENT;

EID: 84893734591     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.12.117     Document Type: Article

References (32)

1. N. Ferrara, and R.S. Kerbel Angiogenesis as a therapeutic target Nature 438 2005 967 974 (Pubitemid 43093963)
2. F. Bussolino, A. Mantovani, and G. Persico Molecular mechanisms of blood vessel formation Trends Biochem. Sci. 22 1997 251 256 (Pubitemid 27310945)
3. F. Shojaei, X. Wu, C. Zhong, L. Yu, X.H. Liang, J. Yao, D. Blanchard, C. Bais, F.V. Peale, N. van Bruggen, C. Ho, J. Ross, M. Tan, R.A. Carano, Y.G. Meng, and N. Ferrara Bv8 regulates myeloid-cell-dependent tumour angiogenesis Nature 450 2007 825 831 (Pubitemid 350231321)
4. C. Murdoch, M. Muthana, S.B. Coffelt, and C.E. Lewis The role of myeloid cells in the promotion of tumour angiogenesis Nat. Rev. Cancer 8 2008 618 631
5. A. Orimo, P.B. Gupta, D.C. Sgroi, F. Arenzana-Seisdedos, T. Delaunay, R. Naeem, V.J. Carey, A.L. Richardson, and R.A. Weinberg Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion Cell 121 2005 335 348 (Pubitemid 40692295)
6. Y. Liu, Z.P. Han, S.S. Zhang, Y.Y. Jing, X.X. Bu, C.Y. Wang, K. Sun, G.C. Jiang, X. Zhao, R. Li, L. Gao, Q.D. Zhao, M.C. Wu, and L.X. Wei Effects of inflammatory factors on mesenchymal stem cells and their role in the promotion of tumor angiogenesis in colon cancer J. Biol. Chem. 286 2011 25007 25015
7. D.I. Gabrilovich, and S. Nagaraj Myeloid-derived suppressor cells as regulators of the immune system Nat. Rev. Immunol. 9 2009 162 174
8. J.I. Youn, S. Nagaraj, M. Collazo, and D.I. Gabrilovich Subsets of myeloid-derived suppressor cells in tumor-bearing mice J. Immunol. 181 2008 5791 5802
9. C.M. Diaz-Montero, M.L. Salem, M.I. Nishimura, E. Garrett-Mayer, D.J. Cole, and A.J. Montero Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy Cancer Immunol. Immunother. 58 2009 49 59
10. S. Ohki, M. Shibata, K. Gonda, T. Machida, T. Shimura, I. Nakamura, T. Ohtake, Y. Koyama, S. Suzuki, H. Ohto, and S. Takenoshita Circulating myeloid-derived suppressor cells are increased and correlate to immune suppression, inflammation and hypoproteinemia in patients with cancer Oncol. Rep. 28 2012 453 458
11. + cells in tumor-bearing host directly promotes tumor angiogenesis Cancer Cell 6 2004 409 421 (Pubitemid 39361441)
12. + myeloid cells Nat. Biotechnol. 25 2007 911 920 (Pubitemid 47236916)
13. C.A. Corzo, T. Condamine, L. Lu, M.J. Cotter, J.I. Youn, P. Cheng, H.I. Cho, E. Celis, D.G. Quiceno, T. Padhya, T.V. McCaffrey, J.C. McCaffrey, and D.I. Gabrilovich HIF-1alpha regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment J. Exp. Med. 207 2010 2439 2453
14. J. Jeon, J. Lee, C. Kim, Y. An, and C. Choi Aqueous extract of the medicinal plant Patrinia villosa Juss. induces angiogenesis via activation of focal adhesion kinase Microvasc. Res. 80 2010 303 309
15. A.K. Horst, T. Bickert, N. Brewig, P. Ludewig, N. van Rooijen, U. Schumacher, N. Beauchemin, W.D. Ito, B. Fleischer, C. Wagener, and U. Ritter CEACAM1+ myeloid cells control angiogenesis in inflammation Blood 113 2009 6726 6736
16. B.P. Eliceiri, R. Klemke, S. Stromblad, and D.A. Cheresh Integrin alphavbeta3 requirement for sustained mitogen-activated protein kinase activity during angiogenesis J. Cell Biol. 140 1998 1255 1263 (Pubitemid 28128883)
17. R. Srinivasan, T. Zabuawala, H. Huang, J. Zhang, P. Gulati, S. Fernandez, J.C. Karlo, G.E. Landreth, G. Leone, and M.C. Ostrowski Erk1 and Erk2 regulate endothelial cell proliferation and migration during mouse embryonic angiogenesis PLoS One 4 2009 e8283
18. Q. Zhou, J. Heinke, A. Vargas, S. Winnik, T. Krauss, C. Bode, C. Patterson, and M. Moser ERK signaling is a central regulator for BMP-4 dependent capillary sprouting Cardiovasc. Res. 76 2007 390 399 (Pubitemid 350007461)
19. M. Kujawski, M. Kortylewski, H. Lee, A. Herrmann, H. Kay, and H. Yu Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice J. Clin. Invest. 118 2008 3367 3377
20. A. Klein-Goldberg, S. Maman, and I.P. Witz The role played by the microenvironment in site-specific metastasis Cancer Lett 2013 10.1016/j.canlet.2013.08.029 pii: S0304-3835(13)00604-6
21. A. Klein, O. Sagi-Assif, S. Izraely, T. Meshel, M. Pasmanik-Chor, C. Nahmias, P.O. Couraud, N. Erez, D.S. Hoon, and I.P. Witz The metastatic microenvironment: Brain-derived soluble factors alter the malignant phenotype of cutaneous and brain-metastasizing melanoma cells Int. J. Cancer 131 2012 2509 2518
22. E. Ribechini, V. Greifenberg, S. Sandwick, and M.B. Lutz Subsets, expansion and activation of myeloid-derived suppressor cells Med. Microbiol. Immunol. 199 2010 273 281
23. D. Gabrilovich Mechanisms and functional significance of tumour-induced dendritic-cell defects Nat. Rev. Immunol. 4 2004 941 952 (Pubitemid 39620069)
24. K. Bajou, V. Masson, R.D. Gerard, P.M. Schmitt, V. Albert, M. Praus, L.R. Lund, T.L. Frandsen, N. Brunner, K. Dano, N.E. Fusenig, U. Weidle, G. Carmeliet, D. Loskutoff, D. Collen, P. Carmeliet, J.M. Foidart, and A. Noel The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies J. Cell Biol. 152 2001 777 784 (Pubitemid 34280162)
25. L. Devy, S. Blacher, C. Grignet-Debrus, K. Bajou, V. Masson, R.D. Gerard, A. Gils, G. Carmeliet, P. Carmeliet, P.J. Declerck, A. Noel, and J.M. Foidart The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent FASEB J. 16 2002 147 154 (Pubitemid 34113008)
26. G. Lazennec, and A. Richmond Chemokines and chemokine receptors: new insights into cancer-related inflammation Trends Mol. Med. 16 2010 133 144
27. E.C. Keeley, B. Mehrad, and R.M. Strieter Chemokines as mediators of tumor angiogenesis and neovascularization Exp. Cell Res. 317 2011 685 690
28. R. Salcedo, M.L. Ponce, H.A. Young, K. Wasserman, J.M. Ward, H.K. Kleinman, J.J. Oppenheim, and W.J. Murphy Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression Blood 96 2000 34 40 (Pubitemid 30456447)
29. S.M. Stamatovic, R.F. Keep, M. Mostarica-Stojkovic, and A.V. Andjelkovic CCL2 regulates angiogenesis via activation of Ets-1 transcription factor J. Immunol. 177 2006 2651 2661 (Pubitemid 44201024)
30. X. Zhuge, T. Murayama, H. Arai, R. Yamauchi, M. Tanaka, T. Shimaoka, S. Yonehara, N. Kume, M. Yokode, and T. Kita CXCL16 is a novel angiogenic factor for human umbilical vein endothelial cells Biochem. Biophys. Res. Commun. 331 2005 1295 1300 (Pubitemid 40692497)
31. M. Gouwy, M. Schiraldi, S. Struyf, J. Van Damme, and M. Uguccioni Possible mechanisms involved in chemokine synergy fine tuning the inflammatory response Immunol. Lett. 145 2012 10 14
32. M. Gouwy, S. Struyf, S. Noppen, E. Schutyser, J.Y. Springael, M. Parmentier, P. Proost, and J. Van Damme Synergy between coproduced CC and CXC chemokines in monocyte chemotaxis through receptor-mediated events Mol. Pharmacol. 74 2008 485 495